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Emergence of Staphylococcus isolates with reduced susceptibility to chlorhexidine is being 13 
increasingly reported. We present an update to a previous report showing continuing efficacy 14 
of chlorhexidine-based infection control measures against Staphylococcus aureus over six 15 
years. We screened qacA/B genes in Staphylococcus isolates collected over another six 16 
years in the same intensive therapy unit in Scotland where chlorhexidine baths form an 17 
essential component of long-term control of nosocomial infections. Consistent with our 18 
previous study we report minimal presence of qacA/B in S. aureus strains from screening 19 
samples and bacteraemia patients but the new finding of a high proportion of qacA/B 20 
carriage in Staphylococcus epidermidis associated to reduced susceptibility to chlorhexidine. 21 
S. epidermidis isolates positive for qacA/B were clonally diverse although 65% of isolates 22 
belonged to the multidrug resistant clone ST-2. These findings raise concerns in relation to 23 
selection of multidrug resistant strains by chlorhexidine and are important in the context of 24 
recent evidence emphasising the benefits of targeting bloodstream infections associated 25 
with coagulase-negative staphylococci. 26 
 27 
KEYWORDS: chlorhexidine baths, intensive therapy unit, Staphylococcus aureus, 28 
Staphylococcus epidermidis, qac genes, multidrug resistance, ST-2. 29 
 30 
1. INTRODUCTION 31 
For over 50 years, chlorhexidine-based preparations have been used with remarkable 32 
success for control of healthcare-associated infections, for example use of chlorhexidine 33 
baths for the prevention and control of methicillin-resistant Staphylococcus aureus (MRSA) 34 
in hospitals (1). It has been recently shown that universal decolonization of patients in 35 
intensive care settings was more effective than targeted strategies in reducing MRSA-36 
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positive clinical cultures and bacteraemias from any pathogen (2, 3). However, the debate 37 
around use of targeted versus universal decolonisation approaches is still ongoing (4). 38 
Indeed, a number of reports have suggested the emergence of Staphylococcus clinical 39 
isolates with decreased susceptibility to chlorhexidine in vitro (5-8), although the clinical 40 
significance of these findings is still controversial (9-11). Phenotypic susceptibility to 41 
chlorhexidine is mostly based on assays which measure MICs and MBCs. Measurement of 42 
chlorhexidine MIC and MBC relates to bacteria tested against much lower concentrations of 43 
chlorhexidine compared to those achieved in clinical practice. The lack of agreed breakpoint 44 
values for biocide susceptibility testing along with other limitations inherent to phenotypic 45 
measurement of susceptibility to disinfectants has hampered the development of 46 
standardised assays (9) and encouraged screening of clinical isolates for genetic markers 47 
potentially associated with resistance. Qac genes encode for proton-dependent efflux pumps 48 
which are known to bind a variety of lipophilic cations including quaternary ammonium 49 
compounds such as chlorhexidine. Of the genes known to be associated with biocide 50 
resistance, qacA has been more strongly associated with decreased susceptibility to 51 
chlorhexidine in Staphylococcus (8, 12). The QacB efflux pump carries amino acid 52 
differences compared with QacA including a substitution from Asp to Ala which determines 53 
inability to bind divalent cations (13). QacA/B genes are located on mobile genetic elements 54 
and their co-presence on plasmids with antibiotic resistance genes has pointed to the 55 
possibility of cross-resistance between biocides and antibiotics in Staphylococcus (10, 14). 56 
However, it is yet unclear whether or not the presence of qac genes selects for the presence 57 
of antibiotic resistance genes. 58 
Another medically important Staphylococcus species is Staphylococcus epidermidis. While 59 
previously considered to be a non-pathogenic skin commensal, it is now recognized a key 60 
opportunistic pathogen associated with nosocomial infections including bacteraemias. Qac 61 
genes have been identified in S. epidermidis (11, 15). Some studies have suggested 62 
horizontal transfer of plasmids carrying qac genes among strains of S. aureus and other 63 
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staphylococci (16). The study here presented was designed as a follow-up to a previous 64 
report showing continuing efficacy of MRSA infection control measures in intensive care 65 
settings and the absence of emergence of resistance over a period of six years (17). We 66 
screened qacA/B genes in Staphylococcus isolates collected over another 6 years in the 67 
same intensive therapy unit (ITU) of a hospital in the North East of Scotland where use of 68 
chlorhexidine baths forms an essential component of long-term control of nosocomial 69 
infections (1). Isolates included MRSA strains from clinical samples obtained from screening 70 
upon admission to the ITU as well as S. aureus and S. epidermidis strains from patients with 71 
bacteraemia. 72 
 73 
2. METHODS 74 
2.1. Setting, intervention and sample collection: This study took place between 75 
November 2007 and February 2014 in the ITU of Aberdeen Royal Infirmary and involved 76 
analysis of eighty-one Staphylococcus isolates. Forty strains of MRSA were randomly 77 
selected from patients screened at multiple body sites on admission over the whole period of 78 
the study. Forty-one strains were obtained from blood cultures and comprised sixteen strains 79 
of S. aureus and twenty-five strains of S. epidermidis. This was a random collection of strains 80 
representing 12% and 32% of the total number of bacteraemias related to S. aureus and S. 81 
epidermidis, respectively, that occurred over the study time period. For both screening 82 
samples and blood cultures one isolate per patient was included in the study. The MRSA 83 
infection control measures following screening have already been described (17). Bacterial 84 
isolation and characterisation was carried out as previously described (17).  85 
2.2  DNA extraction: Genomic DNA was extracted from overnight pure cultures of the 86 
Staphylococcus isolates using the High Pure PCR template preparation kit (Roche 87 
Diagnostics, Germany) following the manufacturer’s instructions. Samples were pre-treated 88 
with 5µl of Lysozyme (Sigma, 10mg/ml) and 4µl of Lysostaphin (Sigma, 10mg/ml) and 89 
incubated for 30 minutes at 37°C for complete lysis of the cell pellet prior to the extraction. 90 
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Genomic DNA was quantified on a Qubit Fluorimeter (Thermo Fisher Scientific, Waltham, MO) 91 
and quality-assessed on a Tapestation (Agilent Technologies, Santa Clara, CA) with genomic 92 
DNA screentapes.   93 
2.3 qacA/B PCR: Bacterial 16S rRNA gene was amplified using the universal eubacterial 94 
primers 27F and 1492R to confirm DNA suitability for further analysis. The 16S rRNA PCR 95 
yielded a product of approximately 1500bp. Qac genes (qacA and qacB) were identified using 96 
previously described specific primers (8) which yielded a product of approximately 800bp.  97 
2.4 Whole genome sequencing: Dual indexed TruSeq libraries were prepared from 98 
200ng of genomic DNA using the TruSeq Nano DNA library preparation kit (Illumina, San 99 
Diego, CA) according to the manufacturer’s instructions using a Bioruptor Pico (Diagenode, 100 
Seraing, Belgium) for fragmentation to 550bp.  Libraries were quantified by qPCR, pooled at 101 
equimolar concentrations and 14pM of the pool was sequenced on a MiSeq using version 3 102 
chemistry and 300bp paired end reads (Illumina, San Diego, CA), with 29.3 million pass filter 103 
reads generated. 104 
2.5 Sequence analyses: Sequences were trimmed using Trimmomatic (18), assembled 105 
using SPAdes (19) and quality-assessed with QUAST (20). The contig files were then 106 
uploaded to the Center for Genomic Epidemiology server 107 
(https://cge.cbs.dtu.dk/services/MLST/ ) for MLST analysis (21). 108 
2.6 Susceptibility testing to antimicrobials: Susceptibility to chlorhexidine was tested 109 
using an agar dilution technique according to the European Committee on Antimicrobial 110 
Susceptibility Testing (EUCAST). Briefly, chlorhexidine digluconate (Sigma-Aldrich, Dorset, 111 
UK) was incorporated into Mueller Hinton agar (Oxoid, Hants, UK) at two-fold dilutions. The 112 
range of concentrations tested was 0.125 to 64 mg/L and inoculation delivered at 104 CFU/spot 113 
using a multipoint replicating device. Incubation was carried out in ambient air at 35 °C for 20 114 
hours. ATCC 29213 and 25923 were used for control strains. The MIC was determined as the 115 
lowest concentration of chlorhexidine that completely inhibited growth. Ethidium bromide was 116 
used as positive control of QacA pump activity and was tested at 4-1024 mg/L. Susceptibility 117 
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testing to 22 antibiotics was carried out using the disc diffusion method according to the 118 
Clinical and Laboratory Standards Institute (CLSI) until 2010. Subsequently, susceptibility 119 
testing to antibiotics was carried out using a Vitek instrument (bioMerieux, Basingstoke, UK) 120 
and the EUCAST guidelines. Antibiotic susceptibility data of selected isolates are reported in 121 
Supplemental table 1. 122 
 123 
3. RESULTS 124 
3.1 Qac typing. Genomic DNA was obtained from all 81 Staphylococcus isolates 125 
investigated in this study, as confirmed by positive detection of the 16S rRNA gene (data not 126 
shown). Of the bacteraemia strains that were found positive for the qacA/B gene, 20 strains 127 
were S. epidermis (Table 1) and 2 strains were S. aureus and accounted for 80% and 13% 128 
respectively of the total S. epidermidis and S. aureus strains isolated from blood samples. 129 
Only 1 out of 40 (2%) MRSA strains isolated from screening samples was found positive for 130 
the qacA/B gene (STAPH12, data not shown). This strain was isolated from a throat swab and 131 
showed 100% homology to qacA (GenBank accession no. HE579074.1) along with the 2 132 
qacA/B positive S. aureus strains from blood cultures.  133 
Sixteen out of 20 (80%) qacA/B positive S. epidermidis isolates from bacteraemia samples 134 
showed 99-100% homology to the full length qacA, while 3 strains (STAPH51, STAPH53, 135 
STAPH59) showed 5-6 nucleotide differences compared to qacA (Table 1). Three of these 136 
single nucleotide polymorphisms result in single amino acid substitutions present in qacB 137 
(C455T, G871A, T1139C) and have been named qacAB in Table 1. Polymorphic sites of qac 138 
nucleotide sequences relative to qacA and respective amino acid substitutions are 139 
summarised in Table 2. STAPH77 appeared to carry only a partial qacA sequence (3’ 450bp 140 
fragment) although a contig break in the middle of the gene and the absence of upstream 141 
sequences hindered detailed analysis of the strain. 142 
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3.2 Susceptibility to chlorhexidine. S. epidermidis strains positive for the full length 143 
qacA/B gene showed minimal but consistent increase of MIC values (2-4 fold) compared to 144 
S. epidermidis negative for qacA/B with the exception of strains STAPH59 (Fig. 1, 145 
supplemental file 2). For all S. epidermidis strains chlorhexidine MICs never exceeded 4 146 
mg/L and there was no evidence of decreasing susceptibility levels to chlorhexidine over the 147 
study period (Fig.1, supplemental file 2). Fig. 1 shows chlorhexidine MICs of S. epidermidis 148 
in relation to ethidium bromide MICs which was used as control in view of the strong 149 
correlation of Staphylococcus resistance to this compound and positivity for the QacAB 150 
efflux pump (8, 22). Indeed, all qacA/B strains investigated in this study returned ethidium 151 
bromide MIC values ≥256 mg/L except for STAPH77 carrying a deleted qacA (Fig.1, 152 
supplemental file 2). Chlorhexidine MIC values for S. aureus isolates fluctuated between 1 153 
mg/L and 4 mg/L and showed no relationship with qac carriage (Supplemental file 2). 154 
3.3 Clonality of qac positive S. epidermidis strains. S. epidermidis isolates positive 155 
for qacA/B were clonally diverse with 13 out of 20 (65%) of isolates belonging to the 156 
multidrug resistant clone ST-2 found prevalent in hospital-acquired infections (23) (Table 1). 157 
Multidrug resistance of qac positive ST-2 S. epidermidis strains was confirmed by sensitivity 158 
testing to a broad range of antimicrobials (Supplemental table 1). Both STAPH51 and 159 
STAPH59 harbouring the highest number of qacA polymorphisms belonged to ST-83 (Table 160 
1). The sequence types accounting for the other 5 qac positive S. epidermidis strains were 161 
ST-5, ST-559, ST-59, and ST-48 (Table 1). As observed for ST-2 these 4 types were also 162 
associated with multidrug resistance (Supplemental table 1) and were distinct from the 5 163 
different sequence types (ST-19, ST-210, ST-54, ST-204 and a new ST) that accounted for 164 
the 5 qac negative S. epidermidis strains (Table 1) which were sensitive to most, if not all, 165 
antimicrobials (Supplemental table 1). 166 
3.4 Genetic determinants for resistance to triclosan and mupirocin. Whole genome 167 
sequencing of S. epidermidis strains revealed genetic determinants for resistance to 168 
mupirocin in 10 of the qac positive strains. A mutation (V588F) of the iso-leucyl tRNA 169 
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transferase gene (ileS) conferring resistance to mupirocin (24) was observed in 5 of these 170 
strains (Table 1). The other 5 strains harboured the ileS2 gene associated with resistance to 171 
mupirocin (25) (Table 1). Sensitivity testing showed high level resistance to mupirocin in 172 
ileS2 isolates tested and low level resistance to mupirocin in 4 out of 5 of the ileS (V588F) 173 
isolates (Supplemental table 1).  The genetic determinants for resistance to triclosan sh-fabI  174 
(enoyl-acyl-carrier protein reductase) (26) and the F204L mutation in gene fabI were 175 
identified in 8 and 2 strains respectively with STAPH51 carrying both determinants (Table 1). 176 
Five of these strains were also mupirocin resistant (Table 1). As previously reported sh-fabI 177 
was co-present on the plasmid harbouring qacA (26), but also observed in qac negative 178 
STAPH67 (Table 1). 179 
 180 
4. DISCUSSION  181 
This study will inform the current debate around use of universal decolonisation versus 182 
approaches to target high-risk pathogens or patient populations that are susceptible to 183 
infection from many pathogens. 184 
We report a very low presence of the qacA gene in S. aureus strains from both screening 185 
samples and bacteraemia patients but a higher proportion (74%) of qacA/B carriage in S. 186 
epidermidis. Qac carriage in S. epidermidis coincided with consistently reduced susceptibility 187 
to chlorhexidine compared to qac negative S. epidermidis. However, chlorhexidine MICs 188 
were stable with no evidence of steady decrease of susceptibility to chlorhexidine over time, 189 
not withstanding that chlorhexidine had already been in widespread use for 6 years before 190 
the start of the present study. Qac positive S. epidermidis strains STAPH59 and STAPH77 191 
did not show reduced susceptibility to chlorhexidine. The latter appeared to carry only the 3’ 192 
450bp portion of the qacA sequence and was sensitive to the control compound ethidium 193 
bromide, suggesting a defective QacA pump in this isolate. In contrast, there was no obvious 194 
correlation between qac carriage in S. aureus isolates and reduced sensitivity to 195 
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chlorhexidine as previously reported (8).  Most qac positive S. epidermidis isolates carried 196 
genes nearly identical to qacA reference genes. S. epidermidis isolate STAPH59 as well as 197 
STAPH51 and STAPH53 showed 5-6 nucleotide differences with respect to qacA although 198 
only 3 of these single nucleotide polymorphisms result in single amino acid substitutions 199 
present in QacB (Table 2). All three strains lacked the three other substitutions which 200 
distinguish QacA from QacB, including the Asp to Ala substitution (D322A) shown to 201 
determine substrate specificity (13). While STAPH59 showed lower chlorhexidine MIC 202 
compared to all other qacA/B S. epidermidis strains, there was no consistent relationship 203 
between carriage of such polymorphic qacA sequences and susceptibility to chlorhexidine. 204 
The widely prevalent multidrug resistant clone ST-2 (23) accounted for the majority of qac 205 
positive S. epidermidis. As previously observed (14) the higher frequency of antibiotic 206 
resistance among qac-carrying strains suggests that chlorhexidine may select for antibiotic 207 
resistance. Nonetheless, presence of five other types amongst qac positive S. epidermidis 208 
isolates was evidence of clonal diversity. ST-83 and ST-5 comprised the strains displaying 209 
the most highly polymorphic qacA sequences. Strains with identical polymorphic qacA gene 210 
sequences have been previously detected in both ST-83 and ST-5 sequence types (27, 28). 211 
 212 
Of interest, whole genome sequencing identified genetic determinants of 2 other biocides 213 
widely used for MRSA decolonisation, albeit not in ITU settings: mupirocin and triclosan. The 214 
V588F ileS mutation or the resistance gene ileS2 conferring mupirocin resistance (24, 25) 215 
were identified in 50% of qac positive isolates. The triclosan resistance determinants sh-fabI 216 
and/or the F204L mutation in fabI (11, 26) were identified in 9 isolates. Notably, in strain 217 
STAPH48 the sh-fabI gene was inserted downstream qacA, suggesting the potential for 218 
horizontal gene transfer of multiple genes associated with reduced susceptibility to biocides 219 
by the same plasmid. This may be particularly true of sh-fabI which was present within a 220 
composite transposon containing the Staphylococcus haemolyticus-derived insertion 221 
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sequence IS1272 (26). Consistently, a previously observed conserved gene coding Sin 222 
recombinase flanking qacR (14) was present on some of the qac-carrying plasmids. 223 
 224 
This study provides no indication of decreased efficacy of chlorhexidine-based infection 225 
control measures against S. aureus infections in the ITU setting described here, or hospital 226 
wide, as already reported (29). Findings are in keeping with our previous report showing no 227 
evidence of decreased susceptibility to chlorhexidine with long-term chlorhexidine bathing in 228 
intensive care over a 6 year period (17).  More recent evidence also shows a lack of 229 
association between extended chlorhexidine use and the prevalence of chlorhexidine-230 
resistant MRSA isolates in outpatient settings (30). Clonal spread, the type of population 231 
under study and differences in infection control policies are likely to account for the higher 232 
prevalence of chlorhexidine resistance genes in S. aureus reported in other studies (5, 6, 233 
31). 234 
The higher proportion of qac gene carriage observed in S. epidermidis, possibly due to long 235 
term chlorhexidine exposure, is concerning. Findings are consistent with a recent study 236 
according to which qac resistance genes were prevalent among S. epidermidis isolates 237 
associated with deep surgical site infections (15). Future larger scale prospective studies will 238 
determine the clinical implications of the high prevalence of qac positive S. epidermidis 239 
strains in this ITU setting. In this context horizontal transfer of resistance genes between S. 240 
epidermidis and S. aureus can be postulated in view of recombinase and IS sequences 241 
flanking determinants for reduced susceptibility to chlorhexidine, triclosan and mupirocin. In 242 
addition the high prevalence of qac in multidrug resistant strains is a concern for selection of 243 
multidrug resistant strains by chlorhexidine as previously reported for S. aureus (10).  244 
 245 
5. CONCLUSIONS 246 
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In conjunction with our previous study, we report a negligible presence of qacA in S. aureus 247 
strains from screening samples and bacteraemia patients over an exceptionally long period 248 
of time. The new finding of a high proportion of qac gene carriage in S. epidermidis could 249 
however be of concern to all intensive care settings where chlorhexidine is used for universal 250 
decolonisation and prevention of bacteraemia. While levels of decreased susceptibility to 251 
chlorhexidine associated with qac gene carriage in S. epidermidis were stable with no 252 
evidence of increasing resistance levels over the study period, most qac positive S. 253 
epidermidis strains belonged to a single multidrug resistance sequence type. This raises 254 
concerns in relation to potential multidrug resistant strain selection by chlorhexidine. Larger 255 
scale prospective studies will determine the clinical relevance of these findings. 256 
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 367 
FIGURE LEGEND 368 
Figure 1: Susceptibility of S. epidermidis isolates to chlorhexidine. Chlorhexidine MICs 369 
are shown in relation to the MICs for ethidium bromide. Each of the twenty-five strains tested 370 
is represented by a symbol. Solid symbols indicate strains carrying qac genes and open 371 
symbols indicate qac negative strains. The MIC values for strain STAPH77 carrying a 372 
truncated qac are also represented by a solid symbol (chlorhexidine MIC = 2 mg/L, ethidium 373 
bromide MIC = 16 mg/L). 374 
 375 
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Table 1: Genetic determinants for reduced biocide susceptibility in S. epidermidis isolates. 379 
Isolate ID Date Sequence 
type (ST) 
Biocide susceptibility genes 
Chlorhexidinea Mupirocinb  Triclosanc  
STAPH48 Jul-09 ST-559 qacA ileS (V588F) sh-fabI 
STAPH49 Jul-09 ST-2 qacA ileS (V588F)  
STAPH51 May-10 ST-83 qacAB ileS2 fabI (F204L), sh-fabI 
STAPH53 May-10 ST-5 qacAB ileS2 sh-fabI 
STAPH54 Jul-10 ST-5 qacA   
STAPH56 Aug-10 ST-2 qacA ileS2 sh-fabI 
STAPH58 Mar-11 ST-2 qacA  sh-fabI 
STAPH59 Apr-11 ST-83 qacAB ileS2 fabI (F204L) 
STAPH60 Aug-11 ST-2 qacA   
STAPH61 Sep-11 ST-2 qacA   
STAPH62 Sep-11 ST-2 qacA   
STAPH63 Sep-11 ST-2 qacA ileS (V588F)  
STAPH64 Oct-11 ST-2 qacA ileS (V588F)  
STAPH66 Apr-12 ST-19    
STAPH67 Jul-12 ST-210   sh-fabI 
STAPH68 Jul-12 ST-54    
STAPH69 Sep-12 ST-2 qacA ileS2  
STAPH70 Dec-12 ST-2 qacA  sh-fabI 
STAPH73 Jan-13 ST-204    
STAPH74 Jan-13 new    
STAPH75 Jan-13 ST-2 qacA ileS (V588F)  
STAPH77 Jun-13 ST-59 qacA (fragment)d  sh-fabI 
STAPH78 Jul-13 ST-2 qacA   
STAPH79 Sep-13 ST-48 qacA   
STAPH83 Feb-14 ST-2 qacA   
a qac gene sequences containing 3 nucleotide changes found in qacB are indicated as 380 
qacAB 381 
b ileS gene mutation or presence of the added gene ileS2 conferring reduced susceptibility to 382 
mupirocin.  383 
c fabI gene mutation or presence of the added gene sh-fabI conferring reduced susceptibility 384 
to triclosan. 385 
d Truncated qacA sequence (only 3’ 450bp fragment).   386 
19 
 









Sequence type (ST) 
Amino acid substitutions 
qacA  GenBank GU565967.1 GCCCTCGGATT   
qacA 48,54,56,58,69,70,71,75,78,79,83 .T......... ST-2, ST-5, ST-48, ST-559  
qacA 49,60,61,62,63,64 .T.G....... ST-2 A157G 
qacAB 51,59 .TT..TAA.C. ST-83 A151V, A184V, V188I, A290T, M379T 
qacAB 53 .TT..T.A.C. ST-5 A151V, A184V, A290T, M379T 
qacB  GenBank AF053772.1 A.T.A..ACC.  V025I, A151V, L166I, A290T, D322A, M379T 
* positions of nucleotide polymorphisms with respect to qacA are written vertically 388 
